NAGE
NAGE clinical trials: Niagen Bioscience, Inc.
Every trial on ClinicalTrials.gov where Niagen Bioscience, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 12
- Trials linked
- 3
- As lead sponsor
- 9
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
NAGE on the catalyst calendar · NAGE registry changes
- Primary completion Dec 4, 2026Sponsor estimateNo phase registeredNCT07774000Efficacy of Topical Niacinamide Riboside on the Signs of Facial Skin AgingChromaDex, Inc. · Skin Aging on FaceRecruitingNAGELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 15, 2026Sponsor estimatePhase 1NCT07251608Randomized, Open-label, Safety Study of Subcutaneous and Intramuscular Injections of Niagen® PlusChromaDex, Inc. · Healthy VolunteerRecruitingNAGELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 26, 2019ActualNo phase registeredNCT03562468A Study by ChromaDex to Assess the Effects of TRU NIAGEN on Cognitive Function, Mood and Sleep in Older AdultsChromaDex, Inc. · Cognitive FunctionCompletedNAGELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 30, 2027Sponsor estimatePhase 2/Phase 3NCT04614714Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm InfantsUniversity of California, Davis · Preterm BirthRecruitingNAGECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 30, 2025Sponsor estimateNo phase registeredNCT06919328Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+Nutraceuticals Research Institute · Healthy AgingRecruitingNAGECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2024Sponsor estimateNo phase registeredNCT06005350Nicotinamide Riboside Impact on Extracellular Nicotinamide Adenine Dinucleotide (NAD+)Charite University, Berlin, Germany · NADUnknown statusNAGECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 1, 2022ActualPhase 1/Phase 2NCT04110028Nicotinamide Riboside in Hospitalized PatientsOslo University Hospital · InflammationCompletedNAGECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 18, 2021ActualPhase 2NCT03642990NR in Chemo-induced Peripheral NeuropathyDonna Hammond, PhD · Chemotherapy-induced Peripheral NeuropathyTerminatedNAGECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 1, 2025Sponsor estimatePhase 2NCT05732051Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer PatientsUniversity Hospital, Akershus · Breast CancerRecruitingNAGECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 17, 2017ActualPhase 2NCT02712593A Study Investigating the Effects of Niagen™ in Healthy Adults.KGK Science Inc. · BioavailabilityCompletedNAGECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2016ActualPhase 1/Phase 2NCT02921659Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older AdultsUniversity of Colorado, Boulder · AgingCompletedNAGECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2014ActualPhase 1NCT02191462A Study of the Pharmacokinetics of Three Dosages of Niagen in Healthy SubjectsKGK Science Inc. · PharmacokineticsCompletedNAGECollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 12 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner